2018
A documentary exploring plant medicines and psychedelics, with an attempt to show a different perspective than the current mainstream narrative. Some of them used for thousands of years as ...
84 min
CLEAR ALL
In part 1 of my Ayahuasca series, you'll learn what to do before the day of the ceremony, so you're better prepared to work with this incredible plant.
Seth - a physician - discusses his experience at the Temple on one of our 12 day ayahuasca and plant spirit healing retreats.
Nearly every culture throughout history has used chemicals that alter consciousness for spiritual exploration. In the 20th century these drugs caught the attention of scientists. Psychedelics, as they were named, proved effective at treating intractable illnesses like depression and addiction.
3
By the mid-1950s, LSD research was being published in medical and academic journals all over the world. It showed potential benefits in the treatment of alcoholism, drug addiction, and other mental illnesses. This film explores those potential benefits, and the researchers who explored them.
As one of our most brilliant and clear-eyed explorers of such topics as plant intelligence and how we feed ourselves, Michael will share his luminous insights from what began as investigative reportage and became a very personal interior journey into the mystery of consciousness and the nature of...
1
Terence McKenna talks about his personal process for using psilocybin mushrooms, attempts to describe some of the experiences he has had while on psychedelics, and what to do if you're experiencing a "bad trip" - he suggests singing.
Psychedelics were the subject of serious medical research in the 1940s to the 1960s, when many scientists believed some of the mind-bending compounds held tremendous therapeutic promise for treating a number of conditions including severe mental health problems and alcohol addiction.
Dr. Roland R. Griffiths is a clinical pharmacologist at Johns Hopkins. Dr. Griffiths has been researching mood-altering compounds for over 40 years, has published over 360 times, and started the psilocybin research program at Johns Hopkins nearly 2 decades ago.
Abstract: Highlighting the results of two fMRI studies and one MEG study with psilocybin and an fMRI study with MDMA, Carhart-Harris will report the effects of both drugs on regional brain activity and brain network organization.
Dr. Robin Carhart-Harris, of the Neuropsychopharmacology Unit, Imperial College London, discusses research on Psilocybin and how psychedelics could be used in therapy to help with depression, addiction, and other problems of rigid thought patterns.